In FSHD muscle cells, MATR3 has been shown to bind to the DUX4 DNA-binding domain and inhibit DUX4-mediated gene expression, thereby reducing apoptosis and improving myogenic defects [55]. This evidence concerns the gene MATR3 and facioscapulohumeral muscular dystrophy.